Physician
Wilkinson, Joanne
Wilkinson, Joanne was paid $1.09M by Medicaid between Jan 2018 and Dec 2024, across 27 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 61% of everything it billed.
33Billing provider infoWILKINSON, JOANNE
BOSTON, MA 02118
BOSTON, MA 02118
33aNPI1174597330assigned 02/15/2006
33bProvider typeInternal Medicine Physician
28Total paid$1.09M
24GClaims11,174
24DCodes billed27
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Massachusetts
Rank by total paid#35 of 1,270
Median peer was paid$8K
This provider vs. median131×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,420 | $139K | |
| 2019 | 791 | $121K | |
| 2020 | 2,449 | $174K | |
| 2021 | 2,766 | $212K | |
| 2022 | 1,376 | $146K | |
| 2023 | 1,548 | $197K | |
| 2024incomplete | 824 | $105K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 61% | 3,849 | 3,618 | $671K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 1,779 | 1,713 | $156K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 2,280 | 2,194 | $138K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 3.4% | 252 | 193 | $38K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.1% | 275 | 234 | $23K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.8% | 268 | 263 | $20K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 402 | 357 | $17K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 226 | 201 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 66 | 65 | $4K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 73 | 72 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 49 | 48 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 75 | 74 | $2K |
15 more codes
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 57 | $2K |
| 80061 | Lipid panel | <1% | 27 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 25 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 25 | $1K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 24 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 30 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $788.53 |
| 3078F | <1% | 485 | $0.72 | |
| 1036F | <1% | 436 | $0.56 | |
| 3074F | <1% | 335 | $0.17 | |
| 4004F | <1% | 16 | $0.09 | |
| 4010F | <1% | 25 | $0.03 | |
| 3079F | <1% | 53 | $0.03 | |
| 3077F | <1% | 15 | $0.02 | |
| 3075F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.